Advertisement

FDA gives Invacare permission to ramp up manufacturing

By Chuck Soder  |  July 26, 2017

Invacare is finally free to build as many wheelchairs as it pleases. The U.S. Food and Drug Administration has given the company permission to ramp up manufacturing at its Elyria, Ohio, plant.

Data Points: Growth in generics doing little to curb drug prices

Data Points: Growth in generics doing little to curb drug prices

By Modern Healthcare  |  July 10, 2017

The Food and Drug Administration in June took steps to increase competition by posting a list of branded drugs that are not protected by patent and are not facing looming generic drug rivals. The agency will fast-track its review of generic drug applications.

FDA combats high drug prices by expediting review of generics

FDA combats high drug prices by expediting review of generics

By Alex Kacik  |  June 27, 2017

The Food and Drug Administration took steps Tuesday to try to curb drug prices by increasing competition in the pharmaceutical market. The agency published a list of off-patent branded drugs without approved generics and will expedite review of generic drugs that have few competitors.

FDA designation 'really big deal' for Athersys

By Crain's Cleveland Business  |  May 29, 2017

The U.S. Food & Drug Administration awarded Athersys' clinical program for stroke fast track designation, an expedited drug development and review program for new drugs or biologics to treat serious or life-threatening conditions.

Addiction experts question FDA's suggestion to cap opioid prescriptions

Addiction experts question FDA's suggestion to cap opioid prescriptions

By Virgil Dickson  |  May 25, 2017

FDA Commissioner Scott Gottlieb has suggested that limiting painkiller prescriptions could be a key tool to battle the opioid addiction crisis gripping the nation. Addiction experts say doctors should have the final say on when and how long the drugs are used.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print